Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation
- PMID: 20006840
- PMCID: PMC2905238
- DOI: 10.1016/j.chom.2009.11.004
Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation
Abstract
Hepatitis C virus (HCV) is a single-stranded RNA virus encoding a single polyprotein whose translation is driven by an internal ribosome entry site (IRES). HCV infection strongly induces antiviral interferon-stimulated gene (ISG) expression in the liver, yet it persists, suggesting that HCV can block ISG effector function. We now show that HCV infection triggers phosphorylation and activation of the RNA-dependent protein kinase PKR, which inhibits eukaryotic translation initiation factor eIF2 alpha and attenuates ISG protein expression despite normal ISG mRNA induction. ISG protein induction is restored and the antiviral effects of interferon are enhanced when PKR expression is suppressed in interferon-treated infected cells. Whereas host protein translation, including antiviral ISGs, is suppressed by activated PKR, HCV IRES-dependent translation is not. These results suggest that the ability of HCV to activate PKR may, paradoxically, be advantageous for the virus during an IFN response by preferentially suppressing the translation of ISGs.
Figures







Comment in
-
Hepatitis C and evasion of the interferon system: a PKR paradigm.Cell Host Microbe. 2009 Dec 17;6(6):495-7. doi: 10.1016/j.chom.2009.11.009. Cell Host Microbe. 2009. PMID: 20006836
Similar articles
-
Hepatitis C and evasion of the interferon system: a PKR paradigm.Cell Host Microbe. 2009 Dec 17;6(6):495-7. doi: 10.1016/j.chom.2009.11.009. Cell Host Microbe. 2009. PMID: 20006836
-
Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells.Gastroenterology. 2014 Aug;147(2):463-72. doi: 10.1053/j.gastro.2014.04.035. Epub 2014 Apr 29. Gastroenterology. 2014. PMID: 24786893
-
PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.Virus Res. 2009 Jun;142(1-2):51-6. doi: 10.1016/j.virusres.2009.01.007. Epub 2009 Feb 2. Virus Res. 2009. PMID: 19189853
-
Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5. Infect Genet Evol. 2013. PMID: 23831932 Review.
-
dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.Viruses. 2012 Oct 29;4(11):2598-635. doi: 10.3390/v4112598. Viruses. 2012. PMID: 23202496 Free PMC article. Review.
Cited by
-
RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity.Front Immunol. 2024 Sep 6;15:1413704. doi: 10.3389/fimmu.2024.1413704. eCollection 2024. Front Immunol. 2024. PMID: 39308856 Free PMC article.
-
Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.J Virol. 2019 Sep 12;93(19):e00148-19. doi: 10.1128/JVI.00148-19. Print 2019 Oct 1. J Virol. 2019. PMID: 31270228 Free PMC article.
-
Viral subversion of the host protein synthesis machinery.Nat Rev Microbiol. 2011 Oct 17;9(12):860-75. doi: 10.1038/nrmicro2655. Nat Rev Microbiol. 2011. PMID: 22002165 Free PMC article. Review.
-
Mammalian orthoreovirus Infection is Enhanced in Cells Pre-Treated with Sodium Arsenite.Viruses. 2019 Jun 18;11(6):563. doi: 10.3390/v11060563. Viruses. 2019. PMID: 31216693 Free PMC article.
-
Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.World J Gastroenterol. 2013 Nov 28;19(44):7852-66. doi: 10.3748/wjg.v19.i44.7852. World J Gastroenterol. 2013. PMID: 24307779 Free PMC article. Review.
References
-
- Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20:17–35. - PubMed
-
- Deutsch M, Hadziyannis SJ. Old and emerging therapies in chronic hepatitis C: an update. J Viral Hepat. 2008;15:2–11. - PubMed
-
- Dreux M, Boson B, Ricard-Blum S, Molle J, Lavillette D, Bartosch B, Pecheur EI, Cosset FL. The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J Biol Chem. 2007;282:32357–32369. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical